What's Happening?
The U.S. Food and Drug Administration (FDA) has classified a nationwide recall of multiple cough drop products as a Class II recall, indicating a moderate risk to consumers. The recall, initiated on March 20, 2026, was prompted by an FDA inspection at an overseas
manufacturing facility that revealed conditions potentially affecting product quality. The affected products, manufactured in China by Xiamen Kang Zhongyuan Biotechnology Co., Ltd., include various flavors and are distributed under several brand names such as Exchange Select and Caring Mill. These products are sold in packages ranging from 25 to 90 counts and have expiration dates in 2026. The FDA's classification suggests that while the likelihood of serious harm is low, the use of these products may cause temporary or medically reversible adverse health effects.
Why It's Important?
This recall is significant as it underscores the importance of maintaining stringent quality control measures in the manufacturing of over-the-counter drug products. The FDA's involvement highlights the agency's role in safeguarding public health by ensuring that products meet safety standards. Consumers who have purchased these products are advised to discontinue use and follow instructions for returns or disposal. The recall also impacts the companies involved, potentially affecting their reputation and financial performance. It serves as a reminder of the global nature of supply chains and the need for rigorous oversight, especially when products are manufactured overseas.
What's Next?
The FDA is expected to continue its oversight and provide updates on the recall status as more information becomes available. This may include corrective actions at the manufacturing site and further guidance to distributors and consumers. Until the recall is formally terminated, the products will remain listed in FDA enforcement records. Consumers are advised to stay informed through official channels and consult healthcare providers if they experience any adverse effects.
